Literature DB >> 27182151

Microfilarial involvement of the neck region: A case report and review of literature.

Varun Kumar Singh1, Abhishek Kashyap2, Harekrushna Sahu1, Geetika Khanna3, Vinay Prabhat1.   

Abstract

INTRODUCTION: Filariasis is caused by parasitic infections, most commonly Brugia malayi and Wuchereria bancrofti. India is one of the endemic countries for such disease. The usually involved organs are lower limbs and external genitalia. Neck region is rarely involved and only a few cases have been reported in literature. CASE REPORT: We reported such a case where filarial involvement has involved the neck region and reached up to the level of upper cervical vertebra. A huge neck swelling and torticollis were the main presenting features. Diagnosis was confirmed by MRI and live presence of microfilarial parasite in FNAC. The patient responded excellently to antihelminthic drugs. He has been under our regular follow-up and there has been no complication till date. DISCUSSION: The purpose of this case report was to highlight this rare presentation of microfilaria parasite.

Entities:  

Keywords:  Antihelminthic drugs; Cervical spine; Microfilaria; Parasite; Torticollis

Year:  2016        PMID: 27182151      PMCID: PMC4857166          DOI: 10.1016/j.jcot.2016.02.004

Source DB:  PubMed          Journal:  J Clin Orthop Trauma        ISSN: 0976-5662


  3 in total

1.  Filariasis presenting as massive diffuse cervical swelling in child.

Authors:  Neeraj Dhameja; B D Bhatia
Journal:  Am J Trop Med Hyg       Date:  2014-01       Impact factor: 2.345

2.  Lymphadenovarix of the head-neck region--a rare presentation of Bancroftian filariasis.

Authors:  Raghav Chandra Dwivedi; Prashant Gupta; Ravi Chandra Dwivedi; Kaushal Kishore; Naresh Bhatia
Journal:  J Trop Pediatr       Date:  2008-12-18       Impact factor: 1.165

3.  Cytological diagnosis of microfilariae in filariasis endemic areas of eastern Uttar Pradesh.

Authors:  Shaila K Mitra; Rajiv K Mishra; Pallavi Verma
Journal:  J Cytol       Date:  2009-01       Impact factor: 1.000

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.